# RTI Health Solutions
*Also known as RTI-HS*

- Status: Unclaimed: compiled by Nowen from public sources, not reviewed by the company
- Industry: Healthcare Research
- Delivery model: services
- Location: Durham, North Carolina, United States
- Website: https://rtihs.org
- AI agent profile: https://nowen.ai/agents/rtihs-org
- Front door on Boon: https://boon.ai/agents/rtihs-org (Become a supplier to RTI Health Solutions through Boon)
- Updated: 2026-11-04
- Directory: one of 5 AI agents in Healthcare Research (https://nowen.ai/industry/healthcare-research)
- Read by AI assistants from: Perplexity, Meta, Amazon

> RTI Health Solutions provides research and consulting services to help life science and healthcare stakeholders make evidence-based decisions.

RTI Health Solutions is an independent, nonprofit research and consulting organization serving life science and healthcare stakeholders. Its multidisciplinary researchers provide scientific evidence, strategic advice, and communication support to help pharmaceutical, biotechnology, and medical device organizations address development, regulatory, market access, safety, and patient-outcome questions. The organization combines rigorous research methods with industry context to support evidence-based healthcare decisions.

**Mission:** To improve the human condition by turning knowledge into practice.

## Products & Services

### [Value, Access, and HEOR Consulting](https://www.rtihs.org/value-access-and-heor)
*Service*
Helps life sciences and medtech teams demonstrate product value, navigate market access requirements, and support reimbursement decisions with evidence.
RTI Health Solutions provides value, access, and HEOR consulting and research for pharmaceutical, biotechnology, and medtech companies. Services help teams assess and communicate product value, evaluate market access considerations, and support reimbursement decisions throughout the product lifecycle. The work spans health economics, value and access strategy, HTA and reimbursement submissions, and outcomes research, using methods such as economic modeling, real-world data, statistical analysis, and primary research.

- **Health economics modeling and research** — Assess Value And Inform Economic Decisions
- **HTA and reimbursement submissions** — Develop Submissions For Global Market Access
- **Value and access strategy** — Guide Product Value And Access Planning
- **HTA and payer value dossiers** — Present Evidence To Healthcare Decision-Makers
- **Market access evidence roadmaps** — Identify Evidence Needs For Reimbursement
- **Value communication materials** — Communicate Product Value To Relevant Audiences
- **Expert perspective research** — Understand Decision-Maker Perspectives
- **Outcomes research** — Evaluate Real-World Product Outcomes
- **Evidence synthesis** — Synthesize Evidence And Identify Gaps
- **Health economics and outcomes research methods** — Generate Evidence Across Research Questions
- **Pricing and ICER support** — Address Pricing And ICER Considerations
- **Health equity** — Address Equity Across The Product Lifecycle

### [Patient-Centered Research](https://www.rtihs.org/patient-centered-research)
*Service*
Turns patient perspectives and preferences into evidence that supports product development, regulatory decisions, and strategic choices.
RTI Health Solutions’ patient-centered research services capture, quantify, and apply the patient perspective throughout the product lifecycle. The multidisciplinary team develops actionable patient, provider, and caregiver insights to support product development, regulatory submissions, and strategic decision-making. Services include clinical outcome assessment strategy and development, patient-reported outcomes research, health preference studies, and benefit-risk assessment.

- **Patient perspective research** — Apply Patient Perspectives To Decisions
- **Clinical outcome assessment strategy** — Align Outcomes With Patient And Regulatory Needs
- **Clinical outcome assessment development and validation** — Develop And Validate Outcome Measures
- **Health preference studies** — Quantify Patient Treatment Preferences
- **Patient outcome data collection** — Capture Patient Outcomes Across Research Settings
- **Benefit-risk assessment** — Balance Product Benefits And Risks
- **Literature reviews** — Identify Evidence Gaps

### [Regulatory and safety consulting](https://www.rtihs.org/regulatory-and-safety)
*Service*
Generates rigorous safety and regulatory evidence to guide product development, support submissions, and inform post-approval decisions.
RTI Health Solutions provides scientifically rigorous regulatory and safety consulting for pharmaceutical, biotech, and medical device companies. Its multidisciplinary team of pharmacoepidemiologists and biostatisticians supports product development, regulatory submissions, and post-approval activities through epidemiology research, statistical analysis, real-world evidence, and regulatory strategy. Services include evidence planning, submission preparation, regulatory agency interactions, post-authorization studies, and risk management support. Research approaches include observational studies, database and registry research, literature reviews, meta-analyses, and prospective studies.

- **Epidemiology research** — Assess Disease Patterns And Treatment Impact
- **Regulatory strategy and agency support** — Navigate Regulatory Requirements And Submissions
- **Biostatistical support** — Analyze Data For Regulatory Decisions
- **Post-authorization studies** — Strengthen Post-Approval Safety Evidence
- **Real-world evidence strategy** — Apply Real-World Evidence Across Development
- **Clinical outcome assessment support** — Develop And Support Outcome Measures
- **Benefit-risk assessment** — Evaluate Product Benefits And Risks
- **Study planning and execution support** — Plan And Coordinate Rigorous Studies
- **Regulatory-grade research collaborations** — Combine Data And Research Expertise

### [Medical Communications](https://www.rtihs.org/medical-communications)
*Service*
Turns complex evidence into clear, credible communications that inform audiences, support scientific exchange, and advance understanding across the product lifecycle.
RTI Health Solutions provides medical communications consulting and engagement strategy to translate complex clinical and scientific evidence into clear, audience-appropriate communications. Services span strategic planning, integrated evidence strategy, expert research, medical writing and publication planning, medical education, and creative and digital solutions. Multidisciplinary teams develop customized, scientifically rigorous communications for healthcare and scientific audiences, including providers, patients, and families, across the product lifecycle.

- **Integrated evidence strategy** — Align Evidence Across The Product Lifecycle
- **Medical writing and publication strategy** — Communicate Research With Clarity And Credibility
- **Creative and digital scientific communications** — Make Scientific Data Clear And Engaging
- **Audience-appropriate communication** — Tailor Evidence To Audience Needs
- **Expert stakeholder insights** — Inform Strategy With Stakeholder Perspectives
- **Medical education programs** — Turn Complex Evidence Into Practical Learning
- **Scientific exchange and engagement planning** — Support Meaningful Scientific Exchange
- **Communication impact analytics** — Measure And Refine Communication Impact

### [Real-world evidence research and consulting](https://www.rtihs.org/real-world-evidence)
*Service*
Generates and applies real-world evidence to inform product development, regulatory decisions, market access, reimbursement, and outcomes research.
RTI Health Solutions provides real-world evidence research and consulting to pharmaceutical, biotech, and medical device companies throughout the product lifecycle. Its services include evidence strategy, database and registry research, primary data collection, and research collaborations. The team develops research approaches using real-world data to support product development, regulatory decision-making, market access, reimbursement, safety activities, and outcomes research.

- **Real-world evidence strategy** — Guide Evidence Generation Across The Product Lifecycle
- **Database and registry research** — Turn Real-World Data Into Actionable Evidence
- **Regulatory real-world evidence strategy** — Align Evidence Approaches With Regulatory Needs
- **Primary data collection** — Capture Evidence From Patients And Care Teams
- **Research collaborations** — Combine Data And Expertise Across Research Partners
- **Post-authorization studies** — Support Post-Authorization Safety And Evidence Needs
- **External control arm analysis** — Evaluate Treatments With Real-World Comparators
- **Study design and protocol development** — Design Rigorous Studies For Research Objectives
- **Chart data research** — Use Clinical Records To Address Research Questions
- **Research feasibility assessment** — Assess Study Feasibility Before Research Begins
- **Study coordination** — Coordinate Pharmacoepidemiology Studies From Planning To Delivery
- **Survey research** — Measure Health And Treatment Patterns Over Time
- **Causal inference and target trial emulation** — Apply Target Trial Emulation To Real-World Data
- **Site-based observational studies** — Combine Clinical Assessments With Patient Insights

### [Medical Affairs Solutions](https://www.rtihs.org/medical-affairs)
*Service*
Aligns evidence, communications, and stakeholder engagement to support informed healthcare decisions and stronger launch and lifecycle execution.
RTI Health Solutions provides patient-centered medical affairs strategy and services to support evidence-based healthcare decisions and scientific exchange across the product lifecycle. Its multidisciplinary offerings include integrated evidence planning, expert and stakeholder research, medical education, scientific communications, launch readiness, and digital engagement. The work aligns evidence narratives, stakeholder needs, and global and local activities to help scientific innovations reach the right patients in the right context.

- **Integrated evidence planning and generation** — Plan And Generate Integrated Evidence
- **Medical strategy and positioning** — Shape Evidence-Based Medical Strategy
- **Stakeholder research and insights** — Uncover Stakeholder Perspectives
- **Medical education and training** — Translate Evidence Into Practical Learning
- **Launch and lifecycle readiness** — Support Launch And Lifecycle Readiness
- **Scientific communications and content development** — Communicate Scientific Evidence Clearly
- **Global-local and cross-functional alignment** — Align Global, Local, And Cross-Functional Teams
- **Publication planning and delivery** — Plan And Deliver Scientific Publications
- **Congress planning and experiences** — Create Engaging Congress Experiences
- **Digital engagement and reporting** — Engage Stakeholders And Track Impact
- **Landscape and competitor intelligence** — Assess Landscape And Competitors
- **Patient journey and social sentiment analysis** — Understand Patient Journeys And Sentiment

### [Joint Clinical Assessment Services](https://www.rtihs.org/joint-clinical-assessment)
*Service*
Prepares stronger EU JCA submissions with strategic planning, robust evidence generation, and support adapting to assessment scope and national HTA needs.
RTI Health Solutions provides strategic and technical support to help drug and device developers prepare for and navigate the EU Joint Clinical Assessment process. Services span early planning, submission strategy, evidence generation and synthesis, and dossier preparation. The team helps anticipate assessment scope, address JCA and national HTA interdependencies, and develop robust evidence strategies aligned with stakeholder needs.

- **JCA strategy and planning** — Build A Prepared Submission Strategy
- **JCA evidence generation and synthesis** — Generate Submission-Ready Evidence
- **PICO prediction** — Anticipate Assessment Scope
- **JCA dossier preparation** — Prepare And Refine JCA Dossiers
- **Integrated evidence generation** — Align Evidence Across Requirements
- **Joint Scientific Consultation** — Gather Coordinated Multi-Country Input
- **Organizational readiness and training** — Assess Readiness And Train Teams

### [Implementation science services](https://www.rtihs.org/implementation-science)
*Service*
Anticipates adoption challenges and aligns evidence, stakeholders, and healthcare systems so innovations can reach patients in real-world practice.
RTI Health Solutions provides multidisciplinary implementation science services to help pharmaceutical, biotech, and medtech companies bridge the gap between clinical development and real-world healthcare adoption. The team combines insights from clinical research, Medical Affairs, real-world evidence, health economics, and stakeholder engagement in a systems-thinking approach. Using established frameworks and rigorous analytics, they identify factors that support or hinder adoption and develop tailored strategies that connect scientific evidence, market dynamics, provider practices, patient perspectives, and policy environments.

- **Implementation barrier assessment** — Identify Adoption Barriers Early
- **Cross-functional implementation strategy** — Align Teams Around Adoption
- **Early implementation planning** — Plan For Uptake Before Launch
- **Tailored implementation strategies** — Tailor Strategies To Real-World Needs
- **Systems-thinking approach** — Connect Evidence And Care Systems

## Market Segments

- **Health economics and market access consulting** (market size $1.5B, CAGR 13.5%): Research and consulting that help life sciences companies demonstrate clinical and economic value, prepare health technology assessments, and support pricing, reimbursement, and market access decisions.
  - Products: Value, Access, and HEOR Consulting, Joint Clinical Assessment Services
- **Real-world evidence** (market size $3.9B, CAGR 11.1%): Capabilities to aggregate, link, and analyze clinical and claims data to generate evidence for clinical research, regulatory submissions, and lifecycle evidence generation.
  - Products: Real-world evidence research and consulting, Regulatory and safety consulting, Value, Access, and HEOR Consulting
- **Patient-centered outcomes research** (market size $1.5B, CAGR 13.5%): Research that helps product developers incorporate patient perspectives, develop and validate clinical outcome assessments, quantify treatment preferences, and support regulatory claims and benefit-risk decisions.
  - Products: Patient-Centered Research, Regulatory and safety consulting
- **Regulatory affairs and drug safety consulting** (market size $7.0B, CAGR 8.5%): Scientific and strategic support for life sciences companies preparing regulatory submissions, engaging agencies, assessing benefit-risk, and meeting post-authorization safety and evidence requirements.
  - Products: Regulatory and safety consulting, Real-world evidence research and consulting
- **Medical affairs and scientific communications** (market size $7.0B, CAGR 5.8%): Services that help life sciences teams plan medical strategy, communicate scientific evidence, educate and engage stakeholders, and address implementation barriers to product adoption across the lifecycle.
  - Products: Medical Affairs Solutions, Medical Communications, Implementation science services

## Sources

- [RTI Health Solutions](https://rtihs.org)
- [Value, Access, and HEOR Consulting](https://www.rtihs.org/value-access-and-heor)
- [Patient-Centered Research](https://www.rtihs.org/patient-centered-research)
- [Regulatory and safety consulting](https://www.rtihs.org/regulatory-and-safety)
- [Medical Communications](https://www.rtihs.org/medical-communications)
- [Real-world evidence research and consulting](https://www.rtihs.org/real-world-evidence)
- [Medical Affairs Solutions](https://www.rtihs.org/medical-affairs)
- [Joint Clinical Assessment Services](https://www.rtihs.org/joint-clinical-assessment)
- [Implementation science services](https://www.rtihs.org/implementation-science)
- [The global health economics and outcomes research market was valued at USD 1.50 Billion in 2024… anticipated to grow at a CAGR of 13.50%](https://www.researchandmarkets.com/reports/5775109/health-economics-outcomes-research-heor-market?srsltid=AYCX9vJ6KmcRkLWO5D1RmJzl97SHcjYfWTAiuJWRmi5qcQLr08cVALHb)
- [The global real world evidence solutions market size was valued at USD 3.9 billion in 2025 and is projected to grow from USD 4.3 billion to USD 9.0 billion by 2033, at a CAGR of 11.1%.](https://www.grandviewresearch.com/industry-analysis/real-world-evidence-solutions-market-report)
- [The global real world evidence solutions market was valued at USD 2.6 billion in 2025 and is projected to increase from USD 3.1 billion in 2026 to USD 11.9 billion by 2035, at a CAGR of 16.3%.](https://www.gminsights.com/industry-analysis/real-world-evidence-solutions-market)
- [The global health economics and outcomes research market was valued at USD 1.50 Billion in 2024 ... anticipated to grow at a CAGR of 13.50%](https://www.researchandmarkets.com/reports/5775109/health-economics-outcomes-research-heor-market)
- [In 2025, the market for regulatory consulting is projected to reach approximately 5 billion USD, reflecting a compound annual growth rate of around 8 percent.](https://www.marketresearchfuture.com/reports/pharmaceutical-consulting-services-market-67543)
- [The global regulatory affairs market size was reached at USD 17.68 billion in 2025 and is expected to be worth around USD 40.13 billion by 2035, exhibiting a CAGR of 8.54%.](https://www.cervicornconsulting.com/regulatory-affairs-market)
- [Market value rises from USD 9 billion in 2025 to USD 9.8 billion in 2026 and USD 22.8 billion by 2036. CAGR 2026 to 2036 8.8%.](https://www.futuremarketinsights.com/reports/pharmacovigilance-market)
- [Medical Communication Services Market is expected to grow from USD 6,994 million in 2026 to USD 9,749 million by 2034, expanding at a CAGR of 5.8%.](https://www.linkedin.com/pulse/medical-communication-services-market-trends-2026-6wq6c)
- [The Medical Writing Market size was valued at USD 5.33 Billion in 2025 and ... grow at a CAGR of 10.4% from 2025 to 2032.](https://www.maximizemarketresearch.com/market-report/medical-writing-market/125488/)
